** Hospitals-chain operator Apollo Hospitals APLH.NS rises about 3.8% to 7,419 rupees
** Stock rises after Citi Research adds Apollo to its Pan-Asia focus list at a "buy" recommendation
** Citi's Pan-Asia focus list is a compilation of its high-conviction stock ideas across the region
** Citi's price target of 9,600 rupees for APLH implies an upside of about 35%
** APLH remains the preferred pick in Indian hospitals space due to its structurally resilient hospital business, a fast-growing pharmacy business and valuations below long-term averages, Citi says
** APLH shares up 1.5% in 2026 so far, resisting the broader market slide in which the Nifty 50 .NSEI has lost 12.7%, exchange data shows
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))